Skip to main content

Table 2 Primary and secondary outcomes

From: Prognostic utility of plasma lactate measured between 24 and 48 h after initiation of early goal-directed therapy in the management of sepsis, severe sepsis, and septic shock

  Analysis group Odds ratio 95 % confidence interval p (alpha level 0.05)
Mortality     
(i) Clearers/nonclearers Unadjusted OR 0.44 (0.24–0.78) 0.005
(ii) Clearers/nonclearers OR adjusted for SOFA 0.45 (0.24–0.85) 0.014
(iii) Clearers/nonclearers OR adjusted SOFA, EGFR, and MELD 0.39 (0.20–0.76) 0.006
Receipt of IV fluids     
(i) Clearers/nonclearers Unadjusted OR 0.72 (0.43–1.22) 0.22
(ii) Clearers/nonclearers OR adjusted for SOFA 0.74 (0.44–1.26) 0.27
(iii) Clearers/Nonclearers OR adjusted SOFA, EGFR, and MELD 0.81 (0.48–1.39) 0.45
Receipt of vasopressors     
(i) Clearers/nonclearers Unadjusted OR 0.46 (0.27–0.79) 0.005
(ii) Clearers/nonclearers OR adjusted for SOFA 0.43 (0.23–0.83) 0.012
(iii) Clearers/nonclearers OR adjusted SOFA, EGFR, and MELD 0.41 (0.21–0.79) 0.008